These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24864512)

  • 41. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down.
    Bateman ED; Jacques L; Goldfrad C; Atienza T; Mihaescu T; Duggan M
    J Allergy Clin Immunol; 2006 Mar; 117(3):563-70. PubMed ID: 16522454
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate.
    Zimmerman B; Gold M; Wherrett D; Hanna AK
    J Allergy Clin Immunol; 1998 Mar; 101(3):425-6. PubMed ID: 9525464
    [No Abstract]   [Full Text] [Related]  

  • 43. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 44. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenal insufficiency after treatment with fluticasone. Dose-response curve should have been highlighted.
    Mohamed ASh
    BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378732
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of salmeterol and fluticasone propionate combination versus fluticasone propionate on airway function and eosinophilic inflammation in mild asthma.
    Hoshino M; Handa H; Miyazawa T
    Allergol Int; 2009 Sep; 58(3):357-63. PubMed ID: 19454840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A rational combination for the treatment of asthma. Salmeterol and fluticasone in one preparation].
    Wettengel R; Steinkamp G
    Pneumologie; 1999 Sep; 53(9):426-32. PubMed ID: 10544652
    [No Abstract]   [Full Text] [Related]  

  • 51. Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult.
    Hindmarsh P
    BMJ; 2002 May; 324(7345):1083. PubMed ID: 11993494
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma.
    Weiler JM; Nathan RA; Rupp NT; Kalberg CJ; Emmett A; Dorinsky PM
    Ann Allergy Asthma Immunol; 2005 Jan; 94(1):65-72. PubMed ID: 15702819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD; Stanford R; Crim C; Yancey SW; Edwards L; Rickard KA; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment.
    Patel L; Wales JK; Kibirige MS; Massarano AA; Couriel JM; Clayton PE
    Arch Dis Child; 2001 Oct; 85(4):330-4. PubMed ID: 11567945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
    Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Yates JC; Vestbo J;
    N Engl J Med; 2007 Feb; 356(8):775-89. PubMed ID: 17314337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
    Li HT; Zhang TT; Zhou H; Qu XJ; Wu WM; Huang J
    Respiration; 2007; 74(1):33-43. PubMed ID: 17008769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Fixed-dose fluticasone-salmeterol combination: at least effective and better tolerated than open-dose combinations].
    Martinat Y; Desfougères JL
    Rev Pneumol Clin; 2003 Jun; 59(3):139-48. PubMed ID: 13130200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for adverse phonatory change following an inhaled combination treatment.
    Erickson E; Sivasankar M
    J Speech Lang Hear Res; 2010 Feb; 53(1):75-83. PubMed ID: 19696437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Vestbo J
    Ugeskr Laeger; 2004 Jan; 166(4):271-4. PubMed ID: 14964108
    [No Abstract]   [Full Text] [Related]  

  • 60. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.
    Bateman ED; Boushey HA; Bousquet J; Busse WW; Clark TJ; Pauwels RA; Pedersen SE;
    Am J Respir Crit Care Med; 2004 Oct; 170(8):836-44. PubMed ID: 15256389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.